dual glp-1/gip agonist Science Behind GLP 1 GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements Dual GIP/GLP-1 receptor agonists: New
Description
Weghuber D, Forslund A, Ahlstrom H, Alderborn A, Bergstrom K, Brunner S, et al
Kaser A, Ludwiczek O, Holzmann S, et al
( Epub 2016/01/10 )
2 T2DM causes changes in cognitive function 2.1 Cognitive impairment in T2DM: stages and risk factors In individuals with T2DM, cognitive functioning undergoes distinct stages of impairment, ranging from diabetes-associated cognitive decrements to MCI and dementia (Tamura et al., 2017)
What Doctors Recommend Doctors are increasingly prescribing GLP-1s for long-term weight and diabetes managementespecially when lifestyle changes alone dont work
